Sentinel node biopsy: an in depth appraisal

Area of Science:

• Oncology
• Surgical Oncology
• Breast Cancer Research

Background:

• Sentinel node biopsy (SNB) is increasingly used in primary breast cancer to reduce complications from axillary node clearance (ANC).
• Several aspects of SNB require further clarification before widespread adoption as standard practice.
• This review addresses the necessity of axillary surgery and evaluates SNB's methodology, outcomes, and potential challenges.

Purpose of the Study:

• To review the current evidence on sentinel node biopsy (SNB) in primary breast cancer.
• To assess the benefits and risks of SNB compared to axillary node clearance (ANC).
• To identify patient subgroups who may gain the most benefit from SNB.

Main Methods:

• Comprehensive literature review of studies on SNB in primary breast cancer.
• Analysis of SNB methodology, including techniques and false negative rates.
• Evaluation of clinical results and long-term consequences of replacing ANC with SNB.

Main Results:

• SNB is a viable alternative to ANC, minimizing surgical morbidity.
• A low false negative rate is inherent to SNB, with a marginal (0.6%) undetectable impact on overall survival.
• Specific patient subgroups are identified as likely to benefit significantly from SNB.

Conclusions:

• SNB is a safe and effective procedure for staging the axilla in primary breast cancer.
• While long-term data is pending, SNB offers a clear advantage in reducing patient morbidity.
• Further research and standardization are needed to establish SNB as best practice for all eligible breast cancer patients.